Upregulation of KIN17 is associated with non-small cell lung cancer invasiveness

Area of Science:

• Molecular Biology
• Oncology
• Cancer Research

Background:

• Kin17 DNA and RNA binding protein (Kin17) is a conserved protein involved in DNA replication, repair, and cell cycle.
• Recent studies highlight Kin17's tumor-promoting functions.
• The role of Kin17 in non-small cell lung cancer (NSCLC) metastasis requires further investigation.

Purpose of the Study:

• To investigate the role of Kin17 in the invasion and metastasis of NSCLC.
• To determine if Kin17 expression correlates with clinical parameters and patient prognosis in NSCLC.
• To explore Kin17 as a potential diagnostic and therapeutic target for NSCLC.

Main Methods:

• Analysis of Kin17 mRNA and protein expression in 97 NSCLC and benign lung tissues.
• Correlation analysis between Kin17 expression, tumor grade, and lymph node metastasis.
• In vitro assays (scratch and Transwell) to assess NSCLC cell migration and invasion after KIN17 knockdown.
• Quantitative polymerase chain reaction and Western blot to evaluate the expression of downstream targets.

Main Results:

• Kin17 mRNA and protein were significantly upregulated in NSCLC tissues compared to benign tissues.
• Elevated Kin17 expression correlated with high tumor grade and lymph node metastasis, indicating poor prognosis.
• Knockdown of KIN17 significantly inhibited NSCLC cell migration and invasion.
• Kin17 knockdown reduced the expression of matrix metalloproteinase 7, epidermal growth factor receptor, and v-myc avian myelocytomatosis viral oncogene homolog.

Conclusions:

• Kin17 is overexpressed in NSCLC and plays a crucial role in promoting tumor cell metastasis.
• Kin17 serves as a potential diagnostic and prognostic biomarker for NSCLC.
• Targeting Kin17 may represent a novel therapeutic strategy for NSCLC treatment.